Localized distribution of human papillomavirus genotypes in the uterine cervix

Introduction: The localization and distribution of single or multiple HPV genotypes in the uterine cervix has not been studied thus far. The present study was undertaken to determine whether single or multiple HPV genotypes detected in cervical smears originate from a single (dysplastic) area, or from different areas (dysplastic or normal) of the uterine cervix.

Methods: Of eight patients with moderate or severe dysplasia, 31 colposcopically guided biopsies of different dysplastic lesions of the uterine cervix, as well as of normal epithelium were investigated. A highly sensitive, broad spectrum, short fragment polymerase chain reaction (SPF-10 PCR) HPV detection method in combination with a line probe assay (LiPA) for simultaneous genotyping was used.

Results: In the uterine cervix of four of the eight patients, multiple HPV genotypes were detected. These multiple HPV genotypes were detected in different biopsies as well as within a single biopsy. In three patients, all with carcinoma in situ or microinvasive carcinoma, only a single HPV genotype, HPV 16, was found all over the cervix including in the normal epithelium.

Conclusion: Different HPV genotypes can be detected in different dysplastic lesions as well as within single lesions, especially in patients with severe dysplasia. The severity of the lesion may possibly have a relation with the distribution of the HPV genotypes. The low number of patients and biopsies does not allow definite conclusions. However, the impact of these findings on the outcome of screening and vaccination programs remains to be elucidated.

HPV, Localization, Distribution, Uterine Cervix

[1] Herrington C. S.: "Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology". J. Clin. Pathol., 1994, 47, 1066.

[2] Chan S. Y., Delius H., Halpern A. L., Bernard H. U.: "Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy". J. Viral., 1995, 69, 3074.

[3] Meijer C. J. L. M.. Rozendaal R., Verheijen R. M., Walboomers J. M. M.: "Clinical role of HPV testing". CME J. Gynecol. Oneal., 2000, 5, 26.

[4] Walboomers J. J. M., Jacobs M. V., Manos M. M., Bosch F. X., Kummer A., Shah K. V. et al.: "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide". J. Pathol., 1999, 189, 12.

[5] Klaes R., Woerner S. M., Ridder R., Wentzensen N., Duerst M., Schneider A. et al.: "Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes". Cancer. Res., 1999, 59, 6132.

[6] Kleter B., van Doorn L. J., ter Schegget J., Schrauwen L., van Krimpen K., Burger M. et al.: "Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses". Am. J. Pathol., 1998, 153, 1731.

[7] Burghardt E., Ostor A. G.: "Site and origin of squamous cervical cancer: a histomorphological study". Obstet. Gynecol., 1983, 62, 117.

[8] Kleter B., van Doom L. J.,S chrauwen L., Molijn A.,S astrowijoto S., ter Schegget J. et al.: "Development and clinical evaluation of a highly sensitive PCR reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus". J. Clin. Microbiol., 1999, 37, 2508.

[9] Melchers W. J., Bakkers J.M., Wang J., de Wilde P. C. M., Boonstra H., Quint W. G. V. et al.: "Short fragment polymerase chain reaction reverse hybridization line probe assay to detect and genotype a broad spectrum of human papillomavirus types. Clinical evaluation and follow-up". Am. J. Pathol., 1999, 155, 1473.

[10] Gravitt P. E., Peyton C. L., Alessi T. Q., Wheeler C. M., Coutlee F.,H ildesheim A. et al.: "Improved amplification of genital human papillomaviruses". J. Clin. Microbiol., 2000, 38, 357.

[11] Herrero R.,H ildesheim A.,B ratti C.,S herman M.,H utchinson M., Morales J. et al.: "Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica". J. Natl. Cancer. Inst., 2000, 92, 464.

[12] Kerstens H. M., Robben J. C., Poddighe P. J., Melchers W. J., Boonstra H., de Wilde P. C. et al.: "Agarcyto: a novel cell-processing method for multiple molecular diagnostic analysis of the uterine cervix". J. Histochem. Cytochem., 2000, 48, 709.

[13] Park J., Sun D., Genest D. R., Trivijitsilp P., Suh I., Crum C. P.: "Coexistence of low and high grade squamous intraepithelial lesions of the cervix: Morphologic progression or multiple papillomaviruses?". Gynecol. Oncol., 1998, 70, 386.

[14] Wright T. C.,R ichart R. M.: "Role of human papillomavirus in the pathogenesis of genital tract warts and cancer". Gynecol. Oncol., 1990, 37, 151.

[15] Hagensee M. E., Slavinsky J., Gaffga C. M., Suros J., Kissmger P., Martin D. H.: "Seroprevalence of human papillomavirus type 16 in pregnant women". Obstet. Gynecol., 1999, 94, 653.

[16] Morrison E. A., Gammon M. D., Goldberg G. L., Vermiund S. H., Burk R. D.: "Pregnancy and cervical infection with human papillomaviruses". Int. J. Gynaecol. Obstet., 1996, 54, 125.

[17] Schneider A., Hotz M., Gissmann L.: "Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women". Int. J. Cancer., 1987, 40, 198.

[18] Sun X. W., Ellerbrock T. V., Lungu 0., Chiasson M. A., Bush T. J., W right T. C.: "Human papillomavirus infection in human immunodeficiency virus-seropositive women". Obstet. Gynecol., 1995, 85, 680.

[19] Vernon S. D., Holmes K. K.: "Human papillomavirus infection and associated disease in persons infected with human immunodeficiency virus". Clin. Infect. Dis., 1995, 2/(suppl), s121.